Mike Fremont cancer prevention diet: 103-year-old runner reveals secret to removing carcinogens and beating arthritis without meds
At 103,
Mike Fremont
isn't just alive, he's thriving. While most people slow down with age, Mike still climbs stairs, paddles his canoe, and lived as a runner till the age of 98. What's his secret? It's not magic or trendy diets. It's about
simple living
, clean eating, and consistency.
Beating Cancer with a Plant-Based Diet
When Mike was 69, doctors told him he had cancer and only three months to live. Instead of surgery, he chose to follow a plant-based
macrobiotic diet
. Inspired by
The Cancer Prevention Diet
by Michio Kushi, Mike changed his life, through food.
He says that after switching his diet, his health began to improve. Over time, his cancer symptoms and even his arthritis went away.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Ein einfacher Trick lindert jahrelange Neuropathie (Heute Abend testen)
Neu Research
Mehr erfahren
What Does Mike Fremont Eat?
Since 1994, Mike has followed a very clean,
plant-based diet
. Here's what he eats daily:
Brown rice
Steamed greens like kale and cabbage
Seaweed
Half a can of beans every day
No meat or dairy
No sugar or packaged food
No fried or oily food
He prefers steaming, boiling, or fermenting his meals.
Staying Active, Naturally
Mike never went to the gym or followed a workout plan. He simply kept moving. He once ran 10 miles three times a week and climbed 48 flights of stairs a day! Even now, he does pull-ups to stay strong.
Live Events
Sleep and Rest Matter
Mike sleeps 8–9 hours every night. He avoids screens and doesn't set alarms, he listens to his body. Good sleep, researchers say, helps the brain and body repair and stay young.
A Simple Life in Nature
Mike also believes in the healing power of nature. He grows some of his own food, avoids chemicals, and loves fresh air. Science agrees, spending time outdoors reduces stress and boosts health.
Inputs from TOI
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Tea or coffee? Which morning drink is better for you
For many people, no morning routine is complete without a caffeinated beverage. Tea or coffee are two of the most consumed beverages worldwide, each offering unique flavors, cultural significance, and a wide range of health benefits. Whether you're a coffee lover or a tea enthusiast, understanding their effects on the human body can help you make more informed choices about your daily brew. Both coffee and tea are packed with antioxidants, offering benefits like brain and heart support, boosted metabolism, and enhanced immune best choice depends on your body's caffeine sensitivity, health needs, and energy levels. It's about how each drink makes you feel. Whether you prefer the bold boost of coffee or the soothing lift of tea, both can be part of a healthy routine when consumed mindfully. Choose based on your individual needs and responses. The 2 famous morning drinks : Tea and coffee Tea is made by steeping dried leaves of the Camellia sinensis plant, with various types like green, black, and white tea produced through different fermentation and drying methods. Tea's key compounds include polyphenols, which act as antioxidants to reduce oxidative stress and inflammation, and amino acids that support brain health and cognitive function. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với sàn môi giới tin cậy IC Markets Tìm hiểu thêm Undo Coffee is brewed from roasted and ground coffee beans, with its composition varying based on brewing method, roasting level, and grinding process. Coffee's key compounds include caffeine, which boosts alertness and dopamine levels, and antioxidants that help reduce inflammation and protect brain cells. Health benefits of tea Tea is more than just a soothing beverage; it's packed with health-promoting compounds. Lowers blood pressure and cholesterol Reduces body inflammation Improves insulin sensitivity and sugar metabolism Prevents cognitive decline and memory issues Provides antioxidants to fight free radicals Green, white, and oolong teas offer unique advantages based on their processing methods, while herbal teas use seeds, roots, and fruits for different health benefits. Health benefits of coffee Coffee is not only a morning energy booster—it also provides several long-term health advantages: Reduces the risk of heart disease and type 2 diabetes Protects against brain diseases like Parkinson's Temporarily lowers blood sugar levels Lowers body inflammation Boosts dopamine production, enhancing mood and mental function Potential risks of overconsumption of tea and coffee Both drinks are usually safe if consumed in moderation; however, over-consumption (especially with coffee) can cause side effects. Coffee can carry some concerns for potential side-effects, including irritability and hyperactivity, anxiety and sleep issues, headaches and tremors, particularly in excessive amounts; and these side-effects can be more or less serious from person to person, primarily depending on caffeine sensitivity and the amount consumed. Tea is typically less risky in moderate consumption, but tea does have caffeine, just not as much as coffee (caffeine levels will depend on the specific tea type). How preparation methods impact tea and coffee nutrients Methods of preparing tea: Traditional tea- A steeped dry leaf tea retains a high polyphenol content. Milk tea- Combining tea with dairy may inhibit the absorption of antioxidants. Methods of preparing coffee: Roasted and ground coffee influences taste, caffeine content, and chemical composition. Brewing methods influence the final antioxidant and nutritional content. Also read | Beer before liquor? How mixing drinks affects your body
Time of India
an hour ago
- Time of India
Altimmune's stock plummets over 60% as liver drug falls short in trial
Altimmune's stock (NASDAQ: ALT) plunged roughly 60–64% in pre-market trading today after it announced mixed results from its mid-stage (IMPACT Phase 2b) trial evaluating its liver drug, pemvidutide , for metabolic dysfunction-associated steatohepatitis (MASH). The drug showed promising results in reducing liver fat and achieving MASH resolution, but failed to deliver strong statistical evidence for fibrosis improvement—a key benchmark in this disease area. What is the current stock price of Altimmune? As of June 26, 2025 , Altimmune is trading at $7.71 per share . This price represents a significant pullback from its recent highs, though it remains above its 52-week low. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo Current price: $7.71 52-week high: $11.16 52-week low: $3.55 Market cap: Estimated between $558 million to $625 million Also Read: US stock futures rise: Dow, S&P 500, and Nasdaq edge higher as Nvidia, BlackBerry, and QuantumScape rally Did pemvidutide meet its primary endpoint? Yes. The trial hit its primary goal: resolution of MASH without worsening liver fibrosis. At 24 weeks: Live Events 59.1% of patients on the 1.2 mg dose saw MASH resolution 52.1% achieved resolution on the 1.8 mg dose Only 19.1% on placebo met this benchmark These results were statistically significant and well above expectations, positioning pemvidutide as a serious contender in the MASH space. Also Read: Intel layoffs 2025: Design engineers, software architects lose jobs - these key divisions are next What about weight loss and secondary benefits? Altimmune also highlighted significant weight loss among trial participants: 5.0% weight loss at 1.2 mg 6.2% at 1.8 mg , compared to 1.0% in placebo This positions pemvidutide alongside other GLP-1 class weight-loss drugs, a category currently generating high investor and consumer interest. Why did the stock crash despite positive results? The issue lies with the fibrosis endpoint. While there were improvements, the trial didn't reach statistical significance in its primary analysis of fibrosis reduction—a major goal in MASH treatment. Though an AI-assisted analysis showed 30.6% of patients had ≥60% reduction in fibrosis (vs. 8.2% placebo), it wasn't enough to reassure investors looking for definitive progress in this area. Are analysts still bullish on Altimmune? Yes, despite the sell-off, Wall Street remains optimistic about Altimmune's long-term prospects. The stock currently holds a "Strong Buy" rating from analysts. That suggests potential upside of nearly 190% from the current price level, assuming pemvidutide regains investor confidence in later trials. What are the short-term stock trends for ALT? Technically, ALT has been highly volatile and is currently trading in the mid-range of its 52-week band . Short-term charts show neutral-to-bearish signals , with some analysts recommending caution until the stock finds support or stabilizes. What is MASH treatment? MASH, short for Metabolic dysfunction-associated steatohepatitis, is the new name for what was previously called NASH (Non-Alcoholic Steatohepatitis). It's a serious form of fatty liver disease that occurs when fat builds up in the liver and causes inflammation and liver cell damage, potentially leading to fibrosis, cirrhosis, or even liver cancer. What's next for Altimmune and pemvidutide? Altimmune will hold an investor webcast to discuss results and plans to meet the FDA for an End-of-Phase 2 meeting by late 2025. A Phase 3 trial is still under consideration. FAQs: What caused Altimmune stock to crash after the MASH trial? The stock crashed after its MASH drug failed to show strong results in improving liver fibrosis. Is Altimmune still moving forward with pemvidutide? Yes, the company plans to meet the FDA and may start a Phase 3 trial.
Time of India
an hour ago
- Time of India
AstraZeneca expands Bengaluru global hub with Rs 166-cr investment
Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs 166 crore, creating 400 jobs to boost Research and Development , global services and AI innovation. The new facility will house nearly 1,300 employees, including 400 new jobs, supporting the company's capabilities in AI-powered innovation across Research and Development, global business services, IT, and digital health operations, AstraZeneca said in a statement. "Our global hub in Bengaluru is a strategic investment that will play a vital role in advancing AstraZeneca's bold ambition to deliver 20 new medicines by 2030 -- by strengthening automated, scalable, data-driven, and patient-centric solutions," AstraZeneca Vice President, Global Business Services, Jackie Crockford said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Best Method for a Flat Stomach After 50 (It's Genius!) Lulutox Undo This is AstraZeneca's second major investment in India within a year after the expansion of its Global Innovation and Technology Centre (GITC) in Chennai. "The combined workforce now at AstraZeneca India Pvt Ltd (AZIPL) will reach close to 4,000 employees, strengthening the company's capability to deliver life-changing medicines to patients worldwide," the company said.
